Commentary on the treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials

Psychopharmacol Bull. 2007;40(3):29-31.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antidepressive Agents / administration & dosage*
  • Depressive Disorder, Major / drug therapy*
  • Female
  • Humans
  • Male
  • Monoamine Oxidase Inhibitors / administration & dosage*
  • Selegiline / administration & dosage*

Substances

  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors
  • Selegiline